Advertisement
Research Article| Volume 156, 107816, October 2019

Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: A systematic review and meta-analysis

      Abstract

      Objective

      To examine the association of comorbid occurrence of diabetes and depression with risk of cardiovascular endpoints including cardiovascular mortality, coronary heart disease and stroke.

      Research design and methods

      A systematic review and metaanalysis. We searched PUBMED/MEDLINE, Medscape, Cochrane Library, CINAHL, EMBASE and Scopus databases assessing cardiac events and mortality associated with depression in diabetes up until 1 December 2018. Pooled hazard ratios were calculated using random- effects models.

      Results

      Nine studies met the inclusion criteria. The combined pooled hazard ratios showed a significant association of cardiac events in people with depression and type 2 diabetes, compared to those with type 2 diabetes alone. For cardiovascular mortality the pooled hazard ratio was 1.48 (95% CI: 1.185, 1.845), p = 0.001, for coronary heart disease 1.37 (1.165, 1.605), p < 0.001 and for stroke 1.33 (1.291, 1.369), p < 0.001. Heterogeneity was high in the meta-analysis for stroke events (I-squared = 84.7%) but was lower for coronary heart disease and cardiovascular mortality (15% and 43.4% respectively). Meta-regression analyses showed that depression was not significantly associated with the study level covariates mean age, duration of diabetes, length of follow-up, BMI, sex and ethnicity (p < 0.05 for all models). Only three studies were found that examined the association of depression in type 1 diabetes, there was a high degree of heterogeneity and data synthesis was not conducted for these studies.

      Conclusions

      We have demonstrated a 47.9% increase in cardiovascular mortality, 36.8% increase in coronary heart disease and 32.9% increase in stroke in people with diabetes and comorbid depression. The presence of depression in a person with diabetes should trigger the consideration of evidence-based therapies for cardiovascular disease prevention irrespective of the baseline risk of cardiovascular disease or duration of diabetes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abdoli S.
        • Hardy L.R.
        • Hall J.
        The complexities of “struggling to live life”.
        The Diabetes Educator. 2017; 43: 206-215
        • Knowler W.C.
        • Barrett-Connor E.
        • Fowler S.E.
        • et al.
        Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
        New England J Med. 2002; 346: 393-403
        • Feng X.
        • Astell-Burt T.
        Impact of a type 2 diabetes diagnosis on mental health, quality of life, and social contacts: a longitudinal study.
        BMJ Open Diabetes Res Care. 2017; 5
        • Lloyd C.E.
        • Pambianco G.
        • Orchard T.J.
        Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-case in individuals with Type I diabetes?.
        Diabet Med. 2010; 27: 234-237
        • Ali S.
        • Stone M.A.
        • Peters J.L.
        • et al.
        The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis.
        Diabet Med. 2006; 23: 1165-1173
        • Khaledi M.
        • Haghighatdoost F.
        • Feizi A.
        • et al.
        The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies.
        Acta Diabetol. 2019; 56: 631-650
        • Lin E.B.
        • Heckbert S.R.
        • Rutter C.M.
        • et al.
        Depression and increased mortality in diabetes: unexpected causes of death.
        Ann Family Med. 2009; 7: 414-421
        • Milani R.V.
        • Lavie C.L.
        Behavioral differences and effects of cardiac rehabilitation in diabetic patients following cardiac events.
        Am J Med. 1996; 100: 517-523
        • van Dooren F.
        • Nefs G.
        • Schram M.
        • et al.
        Depression and risk of mortality in people with diabetes mellitus: A systematic review and meta-analysis.
        PLoS One. 2013; 8: 1-11
        • Park M.
        • Katon W.
        • Wolf F.M.
        Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review.
        Gen Hosp Psychiatry. 2013; 35: 217-225
        • Zhang X.
        • Norris S.
        • Gregg E.
        • et al.
        Depressive symptoms and mortality among persons with and without diabetes.
        Am J Epidemiol. 2004; 161: 652-660
        • Coleman S.M.
        • Katon W.
        • Lin E.
        • et al.
        Depression and death in diabetes; 10-year follow up of all cause and cause specific mortality in a diabetic cohort.
        Psychosomatics. 2013; 54: 428-436
        • Egede L.E.
        Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes.
        Curr Diabetes Rev. 2005; 1: 235-243
        • Bruce D.G.
        • Davis W.A.
        • Starkstein S.E.
        • et al.
        A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study.
        Diabetologia. 2005; 48: 2532-2539
        • Pan A.
        • Lucas M.
        • Sun Q.
        • et al.
        Increased mortality risk in women with depression and diabetes mellitus.
        Arch Gen Psychiatry. 2011; 68: 42-50
        • Song J.W.
        • Chung K.C.
        Observational studies: cohort and case-control studies.
        Plast Reconstr Surg. 2010; 126: 2234-2242
      1. Wells GA, Shea B, O’Connell, D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2012.

        • Modesti P.A.
        • Reboldi G.
        • Cappuccio F.P.
        • et al.
        Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis.
        PLoS One. 2016; 11: e0147601
      2. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available: http://www.cochrane-handbook.org.

        • Higgins J.P.T.
        • Thompson S.G.
        • Deeks J.J.
        • et al.
        Measuring inconsistency in meta-analyses.
        BMJ. 2003; 327: 557-560
        • Egger M.
        • Smith D.
        • Schneider M.
        Bias in meta-analysis detected by a simple, graphical test.
        BMJ. 1997; 315: 629-634
        • StataCorp
        Stata Statistical Software: Release 14.
        StataCorp LP, College Station, TX2015
        • Spitzer R.L.
        • Kroenke K.
        • Williams J.B.
        Validation and utility of a self report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.
        JAMA. 1999; 282: 1737-1744
        • Melchior L.A.
        • Huba G.J.
        • Brown V.B.
        • et al.
        A short depression index for women.
        Educ Psychol Meas. 1993; 53: 1117-1125
        • Gudex C.
        • Kind P.
        The QALY toolkit. Centre for Health Economics.
        University of York, York1989
        • Robins L.N.
        • Helzer J.E.
        • Croughan J.
        National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics and validity.
        Arch Gen Psychiatry. 1981; 38: 381-389
        • Cummings D.M.
        • Kirian K.
        • Howard G.
        • et al.
        Consequences of comorbidity of elevated stress and/or depressive symptoms and incident cardiovascular outcomes in diabetes: results from the reasons for geographic and racial differences in stroke (REGARDS) Study.
        Diabetes Care. 2016; 39: 101-108
        • Bruce D.G.
        • Davis W.A.
        • Dragovic M.
        • et al.
        Comorbid anxiety and depression and their impact on cardiovascular disease in type 2 diabetes: The Fremantle Diabetes Study Phase II.
        Depression Anxiety. 2016; 33: 960-966
        • Clouse R.E.
        • Lustman P.
        • Freedland K.
        • et al.
        Depression and coronary heart disease in women with diabetes.
        Psychosom Med. 2003; 65: 376-383
        • Lin E.B.
        • Rutter C.M.
        • Katon W.
        • et al.
        Depression and advanced complications of diabetes: a prospective cohort study.
        Diabetes Care. 2010; 33: 264-269
        • Sullivan M.D.
        • O’Connor P.
        • Feeney P.
        • et al.
        Depression predicts all-cause mortality. Epidemiological evaluation from the ACCORD HRQL substudy.
        Diabetes Care. 2012; 35: 1708-1715
        • Novak M.
        • Mucsi I.
        • Rhee C.
        • et al.
        Increased risk of incident chronic kidney disease, cardiovascular disease, and mortality in diabetic patients with comorbid depression.
        Diabetes Care. 2016; : 1-8
        • Ting R.
        • Lau E.
        • Ozaki R.
        • et al.
        High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression- A 7-year prospective analysis of the Hong Kong Diabetes Registry.
        J Affect Disord. 2013; 149: 129-135
        • Martin-Subero M.
        • Kroenke K.
        • Diez-Québécois R.
        • et al.
        Depression as measured by PHQ-9 versus clinical diagnosis as an independent predictor of long-term mortality in a prospective cohort of medical in-patients.
        Psychosom Med. 2017; 79: 273-282
        • Hofmann M.
        • Köhler B.
        • Leichsenring F.
        • et al.
        Depression as a risk factor for mortality in individuals with diabetes: a meta-analysis of prospective studies.
        PLoS One. 2013; 21: 8
        • Roy T.
        • Lloyd C.E.
        Epidemiology of depression and diabetes: A systematic review.
        J Affect Disord. 2012; 142: 8-12
        • Lavie C.J.
        • Menezes A.R.
        • De Schutter A.
        • et al.
        Impact of cardiac rehabilitation and exercise training on psychological risk factors and subsequent prognosis in patients with cardiovascular disease.
        Can J Cardiol. 2016; 32: 365-373
        • Kachur S.
        • Menezes A.R.
        • De Schutter A.
        • et al.
        Significance of comorbid psychological stress and depression on outcomes after cardiac rehabilitation.
        Am J Med. 2016; 129: 1316-1321
        • De Schutter A.
        • Lavie C.
        • Milani R.V.
        Relative importance of comorbid psychological symptoms in patients with depressive symptoms following phase II cardiac rehabilitation.
        Postgrad Med. 2011; : 72-78
        • Monster T.B.M.
        • Johnsen S.P.
        • Olsen M.L.
        • et al.
        Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study.
        Am J Med. 2004; 117: 732-737
        • Tata L.J.
        • West J.
        • Smith C.
        • et al.
        General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.
        Heart. 2005; 91: 465-471
        • Cohen H.W.
        • Gibson G.
        • Alderman M.H.
        Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.
        Am J Med. 2000; 108: 2-8
        • Blanchette C.M.
        • Simoni-Wastila L.
        • Zuckerman I.H.
        • et al.
        A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population.
        Ann Epidemiol. 2008; 18: 316-321
      3. Coupland C, Dhiman P, Morriss R. et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011; 343: 1–15.